Patents by Inventor Robert Ashley
Robert Ashley has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).
-
Patent number: 12418535Abstract: A method includes detecting, by an electronic device managing a plurality of integrated circuit (IC) chips, an attempt to modify a whitelist that includes multiple entries of URLs and user IDs and determining whether the attempt is associated with modifying an existing entry, removing the existing entry, or adding a new entry of a URL or a user ID to the whitelist. When the attempt is associated with removing an existing entry corresponding to a particular URL or user ID, the method includes further determining whether the particular URL or user ID is being actively used by IC chip(s). When the attempt to modify or remove the existing entry or add a new entry of a URL or user ID to the whitelist is approved, a notification is transmitted to an electronic communication channel associated with a root administrator and pool managing administrators that manage one or more pool servers.Type: GrantFiled: January 21, 2025Date of Patent: September 16, 2025Assignee: Auradine, Inc.Inventors: Sridhar Chirravuri, Marshall Long, Robert Ashley
-
Patent number: 12192336Abstract: A secure communications and configuration system for digital currency mining systems provides two levels of digital signatures for communications between digital currency mining systems and a central management server where general communications are signed using software generated keys and sensitive communications are signed using an on-board encryption chip. The central management server verifies an initial registration message from a digital currency mining system and send initial configuration data to the digital currency mining system automatically.Type: GrantFiled: June 14, 2024Date of Patent: January 7, 2025Assignee: Auradine, Inc.Inventors: Lei Chang, Robert Ashley, Liang Li
-
Publication number: 20240413974Abstract: Dynamically calculating an optimal operational efficiency configuration of a plurality of digital currency mining systems based on trending information related to the digital currency and extrinsic factors affecting the plurality of digital currency mining. The plurality of digital currency mining systems are sent configuration settings to achieve the optimal operational efficiency configuration.Type: ApplicationFiled: June 7, 2024Publication date: December 12, 2024Inventors: Saptadeep PAL, Patrick XU, David CARLSON, Nicholas CABI, Aditya BATRA, Raju RAKHA, Barun KAR, Rajiv KHEMANI, Robert ASHLEY, Matthew TOMEI, Sridhar CHIRRAVURI
-
Patent number: 12101407Abstract: An asset management method is provided. The asset management method includes establishing a network connection between a cryptomining asset and an asset management server. The asset management method includes generating a digital token, wherein the digital token includes an identifier assigned to the cryptomining asset by a cryptomining asset provider. The asset management method includes transmitting, to the asset management server and via the network connection, the digital token. The asset management method includes receiving, from the asset management server, a message corresponding to the identifier, wherein the message includes a configuration of a cryptomining task. The asset management method includes loading the configuration in the cryptomining asset. Another asset management method and a cryptomining asset are also provided.Type: GrantFiled: November 14, 2023Date of Patent: September 24, 2024Assignee: Auradine, Inc.Inventors: Patrick Xu, Liang Li, Aditya Batra, Sridhar Chirravuri, Lei Chang, Robert Ashley
-
Publication number: 20220323318Abstract: A human oral care composition, includes safe and effective amounts of the fluoride ion and stabilized chlorine dioxide, that may take the form of a paste, gel, rinse, spray, powder, varnish or similar that reduces demineralization and promotes remineralization of teeth. The method includes the topical application of the composition to the human oral cavity (including but not limited to the teeth, gingiva, and tongue), preferably at least once daily, to enhance the anti-caries effect of fluoride by released chlorine dioxide compromising any biofilm present.Type: ApplicationFiled: May 25, 2022Publication date: October 13, 2022Applicant: Micropure, Inc.Inventors: James L. Ratcliff, Lee E. Kirsch, Jessica K. Ward Dykstra, William E. Cooley, Gary Armitage, Robert Ashley, Esmeralda Ann Garcia
-
Publication number: 20160151725Abstract: A water filter in a housing is provided. The housing has an input opening and an output opening to allow the water to be filtered to flow through filter. The output opening has at least one fitting to allow a standard water bottle with a threaded cap closure to attach to the output opening to back flush the filter.Type: ApplicationFiled: December 2, 2015Publication date: June 2, 2016Inventor: Robert Ashley
-
Publication number: 20140112875Abstract: A human oral care composition, includes safe and effective amounts of the fluoride ion and stabilized chlorine dioxide, that may take the form of a paste, gel, rinse, spray, powder, varnish or similar that reduces demineralization and promotes remineralization of teeth. The method includes the topical application of the composition to the human oral cavity (including but not limited to the teeth, gingiva, and tongue), preferably at least once daily, to enhance the anti-caries effect of fluoride by released chlorine dioxido compromising any biofilm present.Type: ApplicationFiled: December 31, 2013Publication date: April 24, 2014Applicant: MICROPURE, INC.Inventors: James L. Ratcliff, Lee E. Kirsch, Jessica K. Ward Dykstra, William E. Cooley, Gary Armitage, Robert Ashley, Esmeralda Ann Garcia
-
Publication number: 20110318282Abstract: A human oral care composition, includes safe and effective amounts of the fluoride ion and stabilized chlorine dioxide, that may take the form of a paste, gel, rinse, spray, powder, varnish or similar that reduces demineralization and promotes remineralization of teeth. The method includes the topical application of the composition to the human oral cavity (including but not limited to the teeth, gingiva, and tongue), preferably at least once daily, to enhance the anti-caries effect of fluoride by released chlorine dioxido compromising any biofilm present.Type: ApplicationFiled: December 22, 2009Publication date: December 29, 2011Applicant: MICROPURE, INC.Inventors: James L. Ratcliff, Lee E. Kirsch, Jessica K. Ward Dykstra, William E. Cooley, Gary Armitage, Robert Ashley, Esmeralda Ann Garcia
-
Publication number: 20090137845Abstract: The present invention provides new chemically modified 4-dedimethylaminotetracycline compounds that can be substituted with aryl, alkenyl, or alkynyl groups. The 7, 8, and/or 9 positions and methods for preparing such compounds. Other tetracycline compounds include the 4-dedimethylaminotetracycline derivatives with an oxime group, NH-Alkyl, or N—NH-Alkyl group substituted at the C4 position as well as C2 Mannich derivatives. The present invention also provides a method of treating a mammal suffering from conditions or diseases by administering to the mammal an effective amount of the new chemically modified tetracycline compounds.Type: ApplicationFiled: October 23, 2008Publication date: May 28, 2009Inventors: Robert Ashley, Joseph J. Hlavka
-
Patent number: 7456158Abstract: The present invention provides new chemically modified 4-dedimethylaminotetracycline compounds that can be substituted with aryl, alkenyl, or alkynyl groups. The 7, 8, and/or 9 positions and methods for preparing such compounds. Other tetracycline compounds include the 4-dedimethylaminotetracycline derivatives with an oxime group, NH-Alkyl, or N—NH-Alkyl group substituted at the C4 position as well as C2 Mannich derivatives. The present invention also provides a method of treating a mammal suffering from conditions or diseases by administering to the mammal an effective amount of the new chemically modified tetracycline compounds.Type: GrantFiled: January 5, 2005Date of Patent: November 25, 2008Assignee: Galderma Laboratories, Inc.Inventors: Robert Ashley, Joseph J. Hlavka
-
Patent number: 7210411Abstract: A round of ammunition for firing from a gun having a rifled barrel, especially a small arms weapon. The projectile (1) forming a part of the round is of steel or other material having a Vickers Hardness value not less than 550, and has a coating (13) of copper or copper alloy. The projectile has a forward body portion (9) which has a diameter similar to that of the lands of the rifling, and a rearward body portion (3) having a diameter which is similar to the diameter defined by the roots of the rifling grooves. The coating (13) is of a thickness not less than the depth of the said rifling grooves, so that the rifling engraves the coating but does not significantly engrave the underlying steel or other hard material. The advantages associated with a hard projectile material are thus obtained without substantially increasing barrel wear.Type: GrantFiled: March 16, 2004Date of Patent: May 1, 2007Assignee: BAE Systems plcInventors: Derek Booth, Adrian David Smith, Robert Ashley
-
Publication number: 20060094697Abstract: A method for simultaneously treating ocular rosacea and acne rosacea in a human in need thereof comprising administering systemically to said human a tetracycline compound in an amount that is effective to treat ocular rosacea and acne rosacea but has substantially no antibiotic activity.Type: ApplicationFiled: November 16, 2005Publication date: May 4, 2006Inventor: Robert Ashley
-
Publication number: 20050209202Abstract: A method of treating rosacea in a human in need thereof comprising administering to said human a tetracycline compound in an amount that is effective to treat rosacea, but has substantially no antibiotic activity.Type: ApplicationFiled: February 18, 2005Publication date: September 22, 2005Inventor: Robert Ashley
-
Publication number: 20050171068Abstract: The present invention provides new chemically modified 4-dedimethylaminotetracycline compounds that can be substituted with aryl, alkenyl, or alkynyl groups. The 7, 8, and/or 9 positions and methods for preparing such compounds. Other tetracycline compounds include the 4-dedimethylaminotetracycline derivatives with an oxime group, NH-Alkyl, or N—NH-Alkyl group substituted at the C4 position as well as C2 Mannich derivatives. The present invention also provides a method of treating a mammal suffering from conditions or diseases by administering to the mammal an effective amount of the new chemically modified tetracycline compounds.Type: ApplicationFiled: January 5, 2005Publication date: August 4, 2005Inventors: Robert Ashley, Joseph Hlavka
-
Publication number: 20050164993Abstract: A method for treating an allergic reaction other than asthma in a mammal need thereof comprising administering to said mammal a tetracycline compound in an amount that is effective to treat said allergic reaction.Type: ApplicationFiled: May 20, 2003Publication date: July 28, 2005Inventor: Robert Ashley
-
Publication number: 20050153943Abstract: A method for simultaneously treating mucositis and fungal infection in a mammal in need thereof, said method comprising administering to said mammal an effective amount of an anti-mucositis and anti-fungal pharmaceutical composition consisting of a tetracycline compound in an amount that is effective to simultaneously treat mucositis and fungal infection, but has substantially no antibiotic activity.Type: ApplicationFiled: May 6, 2003Publication date: July 14, 2005Inventor: Robert Ashley
-
Patent number: 6894036Abstract: The present invention provides new chemically modified 4-dedimethylaminotetracycline compounds that can be substituted with aryl, alkenyl, or alkynyl groups. The 7, 8, and/or 9 positions and methods for preparing such compounds. Other tetracycline compounds include the 4-dedimethylaminotetracycline derivatives with an oxime group, NH-Alkyl, or N—NH-Alkyl group substituted at the C4 position as well as C2 Mannich derivatives. The present invention also provides a method of treating a mammal suffering from conditions or diseases by administering to the mammal an effective amount of the new chemically modified tetracycline compounds.Type: GrantFiled: June 10, 2003Date of Patent: May 17, 2005Assignee: CollaGenex Pharmaceuticals, IncorporatedInventors: Robert Ashley, Joseph J. Hlavka
-
Publication number: 20040244630Abstract: A round of ammunition for firing from a gun having a rifled barrel, especially a small arms weapon. The projectile (1) forming a part of the round is of steel or other material having a Vickers Hardness value not less than 550, and has a coating (13) of copper or copper alloy. The projectile has a forward body portion (9) which has a diameter similar to that of the lands of the rifling, and a rearward body portion (3) having a diameter which is similar to the diameter defined by the roots of the rifling grooves. The coating (13) is of a thickness not less than the depth of the said rifling grooves, so that the rifling engraves the coating but does not significantly engrave the underlying steel or other hard material. The advantages associated with a hard projectile material are thus obtained without substantially increasing barrel wear.Type: ApplicationFiled: April 16, 2004Publication date: December 9, 2004Inventors: Derek Booth, Adrian David Smith, Robert Ashley
-
Publication number: 20040002481Abstract: The present invention provides new chemically modified 4-dedimethylaminotetracycline compounds that can be substituted with aryl, alkenyl, or alkynyl groups. The 7, 8, and/or 9 positions and methods for preparing such compounds. Other tetracycline compounds include the 4-dedimethylaminotetracycline derivatives with an oxime group, NH-Alkyl, or N-NH-Alkyl group substituted at the C4 position as well as C2 Mannich derivatives. The present invention also provides a method of treating a mammal suffering from conditions or diseases by administering to the mammal an effective amount of the new chemically modified tetracycline compounds.Type: ApplicationFiled: June 10, 2003Publication date: January 1, 2004Applicant: CollaGenex Pharmaceuticals, Inc.Inventors: Robert Ashley, Joseph J. Hlavka
-
Patent number: D750737Type: GrantFiled: October 1, 2014Date of Patent: March 1, 2016Assignee: Village Water Filters, Inc.Inventor: Robert Ashley